On second thoughts such is unlikely.
The background was that efficacy was already accepted so the lawyers would not ask that.
That leaves us with the potency assay data.
In person the data before and after could be readily shown in various ways to the FDA's satisfaction.
- Forums
- ASX - By Stock
- MSB
- Australian newspaper article
Australian newspaper article, page-119
-
- There are more pages in this discussion • 107 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.01 |
Change
0.055(5.79%) |
Mkt cap ! $1.084B |
Open | High | Low | Value | Volume |
95.5¢ | $1.03 | 95.0¢ | $2.036M | 2.053M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 50904 | $1.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.01 | 42235 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 38336 | 1.000 |
6 | 59593 | 0.995 |
7 | 55200 | 0.990 |
5 | 22351 | 0.985 |
4 | 28175 | 0.980 |
Price($) | Vol. | No. |
---|---|---|
1.005 | 2281 | 5 |
1.010 | 58628 | 12 |
1.015 | 207337 | 9 |
1.020 | 73883 | 4 |
1.025 | 59600 | 6 |
Last trade - 10.41am 30/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |